PLX insider buying
Every open-market purchase of Protalix BioTherapeutics, Inc. (PLX) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$101.36K
Insiders buying (12m)1
Purchases on record1
Last purchase filedDec 23, 2025
In the last 12 months, 1 insider of Protalix BioTherapeutics, Inc. bought $101.36K of PLX stock on the open market in 1 reported purchase. The most recent was filed on Dec 23, 2025: Bashan Dror (President And CEO, Director) bought 56,000 shares at $1.81, worth $101.36K.
Get the next PLX insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll PLX insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Dec 23 | Bashan DrorPresident And CEO, Director | $101.36K | 56,000 | $1.81 | +42% | Dec 19 | SEC |